Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-16

Clinical Trial Update: Spinal Cord Stimulation in Spinal Muscular Atrophy [NA]

View source ↗

Summary

A completed clinical trial evaluating a spinal cord stimulator in patients with Spinal Muscular Atrophy (Types 3 and 4) has posted results as of March 16, 2026.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spinal cord stimulator (spinal cord stimulator)

Snippet

Sponsor: Marco Capogrosso | Conditions: Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy Type 4 | NA | Status: COMPLETED | Results posted: 2026-03-16